News and Trends 11 Oct 2022 Clinical Microbiomics expanding with €10M million investment Danish microbiome research company Clinical Microbiomics A/S has received €10 million ($9.7 million) in funding from Seventure Partners. Clinical Microbiomics, founded in 2015, is a microbiome analysis company, which includes work on clonal-level microbiome profiling. The company is working with food and consumer health companies and is supporting the pharmaceutical industry in phase 3 clinical […] October 11, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 15 Sep 2022 Novome Biotechnologies raises $43.5M for therapeutically engineered microbes pipeline U.S. biotech company Novome Biotechnologies, Inc., has closed a $43.5 million series B financing round. The financing was led by Tencent, and includes new investors University of Minnesota, Navian Investments, Colorcon Ventures and Touchdown Ventures. Existing investors DCVC Bio, 5AM Ventures, Alta Partners and Alexandria Venture Investments also participated. The proceeds will be used to […] September 15, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 14 Sep 2022 NTU Singapore opens microbiome research center to study obesity and chronic diseases Nanyang Technological University, Singapore (NTU Singapore) has created the Centre for Microbiome Medicine – a research facility that aims to improve human health and find new ways to treat diseases by leveraging the microbiome, which are naturally present microorganisms that play a vital role in our wellbeing. The research centre at NTU Singapore’s Lee Kong […] September 14, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Sponsored by Computomics 30 Aug 2022 Metagenomics: unlocking the secrets of microbial communities The combination of advanced sequencing technologies and user-friendly data analysis solutions is bringing metagenomics into the reach of more scientists, creating new opportunities to ask and answer exciting research questions. New ways to look at microbes Metagenomics is a relatively new field that is radically changing how microbial analyses are performed and making it possible […] August 30, 2022 - 6 minutesmins - By Julia Kaiser Share WhatsApp Twitter Linkedin Email
More News! 19 Jul 2022 Bayer Consumer Health launches microbiome research call to find new academic partners Campaign launch date: Monday, July 18, 2022. Bayer Consumer Health has launched a call through IN-PART’s Discover platform to find and partner with academic experts and research groups working on microbiome-targeting solutions for upper respiratory illnesses, nutrition and digestive health as well as topical delivery through the skin. The campaign aims to accelerate Bayer’s “Partnering […] July 19, 2022 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
More News! 13 Jul 2022 Paradigm of treatment of mental health to be transformed by gut-brain development program Building on a decade of research, a development program for next-generation probiotics and therapeutics to modulate gut microbiota and mental health has been launched. Seed Health, a microbiome science company along with Axial Therapeutics, a clinical stage biopharmaceutical company announced the joint program in the US today (July 13). It will build on the work […] July 13, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jul 2022 Novartis Pharmaceuticals UK launches health-tech investor partnership for cardiovascular care Novartis Pharmaceuticals UK has launched the Novartis Biome UK Heart Health Catalyst 2022, in a world-first investor partnership with Medtronic ltd, RYSE Asset Management, and Chelsea and Westminster Hospital NHS Foundation Trust and its official charity CW+. The initiative aims to identify and implement solutions that empower patients to improve their heart health, and to […] July 5, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jun 2022 Fermentation facility opens its doors in Wisconsin A new fermentation facility producing food ingredients and cultures, bacterial cultures, and probiotics has been opened in Franksville, Wisc., by Cultures Supporting Life (CSL). The ingredients, cultures and probiotics produced will be used in dairy, food, dietary supplements, pharma, and agriculture. Kyle Griffiths, vice president of sales and marketing said: “The new production facilities located […] June 27, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 6 Jun 2022 Releasing the microbiome’s potential to restore European soils For decades, soil has been treated as an everlasting food machine rather than as a fragile living thing, and it is reaching a crisis point. Understanding how the soil microbiome interacts with the environment and helping farmers embrace new sustainable methods can have a beneficial impact on the soil, and consequently, our health. After years […] June 6, 2022 - 9 minutesmins - By Carlos de Rojas Share WhatsApp Twitter Linkedin Email
News and Trends 23 Mar 2022 Ilya Pharma Paves Way for Bacterial Gene Therapy with €8.5M Funding Cell and gene therapies are taking off in a big way in Europe. As the buzz grows, the Swedish firm Ilya Pharma has raised €8.5M to lay down the foundations of bacterial gene therapies for enterocolitis and diabetic ulcers. Investor interest in cell and gene therapy is ramping up fast around the world, with a […] March 23, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Mar 2022 Microbiome Space in Spotlight as Microbiotica Sets Funding Record Competition is heating up in the microbiome niche as UK-based Microbiotica raised €60M (£50M) in a Series B round to advance two candidates designed to treat cancer and ulcerative colitis. Microbiotica’s financing sets a record in Europe for microbiome specialist biotechs. The round was co-led by Sweden’s Flerie Invest and China-based Tencent, and was supported […] March 11, 2022 - 3 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 15 Sep 2021 UK Startup Surfs Investment Wave in Microbiome with €18M Series A As increasing attention turns to microbiome-based therapeutics, the Scottish biotech Enterobiotix has closed a Series A fundraising to potentially treat a myriad of medical conditions by improving gut health. Last week, EnteroBiotix raised €18M (£15.5M) in Series A funding to further develop a pill to restore the patient’s gut microbiome to a healthy state using […] September 15, 2021 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email